[Analysis of the pharmacodynamic properties of the nicotinic ester of 7-(2-hydroxyethyl)-theophylline. II. Cardiocirculatory effects in subjects with cerebral and peripheral angiopathies].
D001162:Arteriosclerosis Obliterans / Q000188:drug therapy; D002319:Cardiovascular System / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D009539:Nicotinic Acids / Q000627:therapeutic use*; D011928:Raynaud Disease / Q000188:drug therapy; D013806:Theophylline / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000188:drug therapy*
D009539:Nicotinic Acids; D013806:Theophylline
Analisi delle proprietà farmacodinamiche dell'estere nicotinico della 7-(2-idrossietil)-teofillina. II. Effetti cardiocircolatori in soggetti con angiopatie cerebrali e periferiche.